Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03018405 |
| Title | A Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Cancer Indications (THINK) |
| Acronym | THINK |
| Recruitment | Unknown status |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Celyad Oncology SA |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | BEL |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| RECRUITING | Tampa | Florida | 33612 | United States | Details | |
| RECRUITING | Buffalo | New York | 14263 | United States | Details | |
| RECRUITING | Brussels | 1200 | Belgium | Details | ||
| RECRUITING | Brussels | Belgium | Details | |||
| RECRUITING | Ghent | Belgium | Details |